Catalyst Wire Dossier Catalyst Wire Dossier

NDV-3A vaccine

NDV-3A · NovaDigm Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NDV-3A vaccine, covering 2018-06-20 to 2020-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of One Dose of NDV 3A Vaccine in People With STAT3-Mutated Hyper-IgE Syndrome [Phase 2]

See pricing